Disease-modifying antirheumatic drug - PDFSEARCH.IO - Document Search Engine

Disease-modifying antirheumatic drug
Results: 192

#	Item
121	Hydroxychloroquine(HCQ) reduces the risk of coronary artery disease in patients with rheumatoid arthritis(RA) Chun Li Department of Rheumatology and Immunology Center Add to Reading List Source URL: aplarcongress.org Language: English - Date: 2014-04-22 21:42:29 Rheumatoid arthritis Disease-modifying antirheumatic drug Hebei Coronary artery disease Medicine Health Anatomy Arthritis
122	Providing Affordable Treatment: Biosimilar Agents Dae Hyun Yoo, M.D. Rheumatology and Internal Medicine Add to Reading List Source URL: aplarcongress.org Language: English - Date: 2014-04-23 05:34:26 Biotechnology Abatacept Disease-modifying antirheumatic drug Etanercept Biologic Rheumatology Rituximab Eisai Adalimumab Pharmacology Immunosuppressants Medicine
123	Large Joint Destruction Treated With Conventional DMARDs Therapy In 167 Early RA Patients Followed up For 10 To 25 Years Department of Rheumatology , Add to Reading List Source URL: aplarcongress.org Language: English - Date: 2014-04-22 21:47:23 Disease-modifying antirheumatic drug Ra
124	FOOD AND DRUG ADMINISTRATION (FDA) Center for Drug Evaluation and Research (CDER) Arthritis Advisory Committee (AAC) Meeting FDA White Oak Campus, Building 31, The Great Room (Rm[removed]White Oak Conference Center, Silve Add to Reading List Source URL: www.fda.gov Language: English Anatomy Rheumatoid arthritis Disease-modifying antirheumatic drug Tofacitinib Anakinra Leflunomide Immunosuppressants Immunology Pharmacology
125	FOOD AND DRUG ADMINISTRATION (FDA) Center for Drug Evaluation and Research (CDER) Arthritis Advisory Committee (AAC) Meeting FDA White Oak Campus, Building 31, The Great Room (Rm[removed]White Oak Conference Center, Silve Add to Reading List Source URL: www.fda.gov Language: English Immunology Rheumatoid arthritis Disease-modifying antirheumatic drug Tofacitinib Arthritis Anakinra Leflunomide Medicine Immunosuppressants Health
126	DOC Document Add to Reading List Source URL: www.ccfa.org Language: English - Date: 2012-05-31 14:50:52 Monoclonal antibodies Autoimmune diseases Pharmacology Abdominal pain Gastroenterology Adalimumab Infliximab Management of ulcerative colitis Disease-modifying antirheumatic drug Medicine Health Immunosuppressants
127	PDF Document Add to Reading List Source URL: www.fda.gov Language: English Pharmacology Amgen Etanercept Wyeth Rheumatoid arthritis Tumor necrosis factor-alpha Disease-modifying antirheumatic drug Placebo Biologic Medicine Immunosuppressants Biology
128	Food and Drug Administration Center for Drug Evaluation and Research Summary Minutes of the Arthritis Advisory Committee Meeting May 9, 2012 Location: Add to Reading List Source URL: www.fda.gov Language: English Health Monoclonal antibodies Arthritis Rheumatoid arthritis Adalimumab Tofacitinib Disease-modifying antirheumatic drug Food and Drug Administration Anakinra Immunosuppressants Pharmacology Medicine
129	PDF Document Add to Reading List Source URL: www.fda.gov Language: English Immunosuppressants Clinical research Amgen Etanercept Rheumatoid arthritis Tumor necrosis factor-alpha Biologic Disease-modifying antirheumatic drug Placebo Medicine Health Pharmacology
130	Sulfasalazine (Azulfidine) Description Sulfasalazine (Azulfidine), used to treat pain and swelling in arthritis, belongs to a class of drugs called sulfa drugs. It is a combination of salicylate (the main ingredient in a Add to Reading List Source URL: www.rheumatology.org Language: English Rheumatology Arthritis Sulfonamides Connective tissue diseases Sulfasalazine Rheumatoid arthritis Psoriatic arthritis Disease-modifying antirheumatic drug Ulcerative colitis Medicine Health Autoimmune diseases